Article
Disease‐modifying therapies in Alzheimer's disease
18 Feb 2008
Abstract excerpt
Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substantial burden on patients, their families, and society. The disease affects approximately 5 million individuals in the United States, with an annual cost of care greater than $100 billion. During the past dozen years, several agents have been approved that enhance cognition and global function of AD patients, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
